Alcidion Group Limited (AU:ALC)
ASX:ALC
Want to see AU:ALC full AI Analyst Report?
ALC Stock Chart & Stats
AU$0.10
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.10
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.08 - AU$0.15
Previous CloseN/A
Volume609.88K
Average Volume (3M)796.98K
Market Cap
AU$147.79M
Enterprise ValueAU$131.49M
Total Cash (Recent Filing)AU$14.20M
Total Debt (Recent Filing)AU$1.32M
Price to Earnings (P/E)34.7
Beta0.95
Next Earnings
Sep 02, 2026Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding1,343,558,700
10 Day Avg. Volume536,053
30 Day Avg. Volume796,979
Financial Highlights & Ratios
PEG Ratio-0.70
Price to Book (P/B)1.57
Price to Sales (P/S)3.38
P/FCF Ratio24.47
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.15Price Target Upside47.50% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)<0.01
Revenue Forecast (FY)AU$47.55M
Bulls Say, Bears Say
Bulls Say
Very High Gross MarginsAn 88.24% gross margin is characteristic of software-led healthcare solutions and implies strong unit economics. High gross margins provide durable operating leverage as revenue scales, allowing the company to fund R&D, customer support and sales expansion without proportional increases in cost of goods sold.
Strong Free Cash Flow ImprovementA dramatic FCF improvement and near-1.0 FCF-to-net-income ratio indicate the business is converting reported profit into cash reliably. This durable cash generation reduces financing needs, supports reinvestment in product and deployments, and cushions the company across multi-month contracting cycles.
Recurring, Services-linked Revenue ModelA mix of subscription/license fees plus implementation and ongoing support creates recurring and multi-year revenue streams. This business model fosters customer stickiness and predictable renewal-driven cash flows, helping revenue visibility and scaling opportunities within health systems over quarters.
Bears Say
Negative EBIT MarginA negative EBIT margin signals the company still faces operating inefficiencies or elevated sales/engineering costs relative to revenue. Persisting negative EBIT over multiple quarters would limit internal funding for growth and require sustained margin improvement to achieve durable, standalone profitability.
Thin Net ProfitabilityA 4.06% net margin provides a narrow earnings buffer against contract losses or higher operating expenses. For a software-centric healthcare vendor, such thin net profitability may constrain the ability to self-fund expansions, reduce capital return potential, and extend the time needed to reach consistent, robust returns.
Modest Return On EquityAn ROE near 1.9% suggests shareholder capital is generating limited returns relative to expectations for growth software businesses. Over the medium term this may reflect constrained profitability or inefficient capital deployment, weakening the case for equity-funded expansion absent clear ROE improvement.
Alcidion Group Limited News
ALC FAQ
What was Alcidion Group Limited’s price range in the past 12 months?
Alcidion Group Limited lowest share price was AU$0.08 and its highest was AU$0.14 in the past 12 months.
What is Alcidion Group Limited’s market cap?
Alcidion Group Limited’s market cap is AU$147.79M.
When is Alcidion Group Limited’s upcoming earnings report date?
Alcidion Group Limited’s upcoming earnings report date is Sep 02, 2026 which is in 89 days.
How were Alcidion Group Limited’s earnings last quarter?
Alcidion Group Limited released its earnings results on Feb 25, 2026. The company reported AU$0.001 earnings per share for the quarter, beating the consensus estimate of AU$0 by AU$0.001.
Is Alcidion Group Limited overvalued?
According to Wall Street analysts Alcidion Group Limited’s price is currently Undervalued.
Does Alcidion Group Limited pay dividends?
Alcidion Group Limited does not currently pay dividends.
What is Alcidion Group Limited’s EPS estimate?
Alcidion Group Limited’s EPS estimate is 0.
How many shares outstanding does Alcidion Group Limited have?
Alcidion Group Limited has 1,343,558,700 shares outstanding.
What happened to Alcidion Group Limited’s price movement after its last earnings report?
Alcidion Group Limited reported an EPS of AU$0.001 in its last earnings report, beating expectations of AU$0. Following the earnings report the stock price went down -4.545%.
Which hedge fund is a major shareholder of Alcidion Group Limited?
Currently, no hedge funds are holding shares in AU:ALC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Alcidion Group Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
AU$0.15 (47.50% Upside)
AU$0.15 (47.50% Upside)
Blogger Sentiment
Bullish
AU:ALC Sentiment 100%
Sector Average ―
Sector Average ―
Technicals
SMA
Positive
20 days / 200 days
Momentum
66.66%
12-Months-Change
Fundamentals
Return on Equity
4.37%
Trailing 12-Months
Asset Growth
3.82%
Trailing 12-Months
Company Description
Alcidion Group Limited
Alcidion Group Limited, together with its subsidiaries, engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom. The company offers Miya Precision, a consolidated fast healthcare interoperability resource (FHIR) based platform to deliver smart healthcare; Smartpage, a smartphone and web-based system for hospital communication and task management to address the requirements of clinical and non-clinical users; Patientrack, a real-time patient monitoring and risk screening solution; Silverlink, a patient administration system; and ExtraMed, a clinical and patient flow management software. It also provides product implementation, product support and maintenance, systems integration, and data analysis services. The company was formerly known as Alcidion Corporation Pty Ltd and changed its name to Alcidion Group Limited in December 2015. Alcidion Group Limited was founded in 2000 and is headquartered in South Yarra, Australia.
ALC Stock 12 Month Forecast
Average Price Target
AU$0.15
▲(47.50% Upside)
Technical Analysis
Oneview Healthcare Chess Depository Interests repr 1
―
Mach7 Technologies
―
Beamtree Holdings Ltd
―
Singular Health Group Ltd
―
PainChek Ltd
―
Options Prices
Currently, No data available
---